Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 56.52 CNY 0.52% Market Closed
Market Cap: 9.5B CNY

Acrobiosystems Co Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Acrobiosystems Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
Net Income (Common)
ÂĄ123.8m
CAGR 3-Years
-11%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Income (Common)
-ÂĄ5B
CAGR 3-Years
20%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income (Common)
ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Net Income (Common)
-ÂĄ514.5m
CAGR 3-Years
22%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
ÂĄ106.2m
CAGR 3-Years
-63%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Net Income (Common)
-ÂĄ266.8m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
9.5B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
56.82 CNY
Undervaluation 1%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's Net Income (Common)?
Net Income (Common)
123.8m CNY

Based on the financial report for Dec 31, 2024, Acrobiosystems Co Ltd's Net Income (Common) amounts to 123.8m CNY.

What is Acrobiosystems Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
62%

Over the last year, the Net Income (Common) growth was -19%. The average annual Net Income (Common) growth rates for Acrobiosystems Co Ltd have been -11% over the past three years , 62% over the past five years .

Back to Top